Jubilant Ingrevia’s share price is likely to remain in focus today after the company’s board approved entering into a binding term sheet to acquire a 40% strategic equity stake in Zettaone Technologies India for approximately ₹189.2 crore. Following the completion of the transaction, Zettaone will become an associate company of Jubilant Ingrevia. The acquisition will be completed in two tranches, with the first tranche expected to close by November 2026 and the second by September 2027. The development comes after a strong June quarter for the company. Jubilant Ingrevia reported a 41% year-on-year increase in consolidated net profit, while revenue from operations rose 25.3%. EBITDA increased 40% year-on-year. In the previous trading session, the stock closed at ₹725.90, down ₹6.40. The stock has traded between a 52-week high of ₹794.95, recorded on July 22, 2026. At its previous close, the stock was 8.69% below its 52-week high. Jubilant Ingrevia currently has a market capitalisation of approximately ₹11,562.22 crore.

#StockInNews

809 likes·35 comments